Literature DB >> 16645151

Signaling and functions of angiopoietin-1 in vascular protection.

Nicholas P J Brindle1, Pipsa Saharinen, Kari Alitalo.   

Abstract

Angiopoietin-1 (Ang1) has powerful vascular protective effects: suppressing plasma leakage, inhibiting vascular inflammation, and preventing endothelial death. Preclinical studies indicate that Ang1 may be therapeutically useful in a number of situations, including treatment of edema, endotoxemia, and transplant arteriosclerosis. However, the ligand has also been implicated in vessel remodeling, induction of angiogenesis and pulmonary hypertension, indicating that strategies to minimize any deleterious effects while optimizing vessel protection are likely to be needed. This review surveys the published data on vascular protective effects of Ang1 and highlights the therapeutic potential of this ligand, as well as possible limitations to its use. We also consider the data on Ang1 receptors and speculate on how to maximize therapeutic benefit by targeting the Tie receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16645151      PMCID: PMC2270395          DOI: 10.1161/01.RES.0000218275.54089.12

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  118 in total

1.  Angiopoietins have distinct modular domains essential for receptor binding, dimerization and superclustering.

Authors:  Samuel Davis; Nick Papadopoulos; Thomas H Aldrich; Peter C Maisonpierre; Tammy Huang; Lubomir Kovac; April Xu; Raymond Leidich; Elzbieta Radziejewska; Ashique Rafique; Judah Goldberg; Vivek Jain; Kevin Bailey; Margaret Karow; Jim Fandl; Steven J Samuelsson; Ella Ioffe; John S Rudge; Thomas J Daly; Czeslaw Radziejewski; George D Yancopoulos
Journal:  Nat Struct Biol       Date:  2003-01

2.  Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Authors:  Nicholas W Gale; Gavin Thurston; Sean F Hackett; Roumiana Renard; Quan Wang; Joyce McClain; Cliff Martin; Charles Witte; Marlys H Witte; David Jackson; Chitra Suri; Peter A Campochiaro; Stanley J Wiegand; George D Yancopoulos
Journal:  Dev Cell       Date:  2002-09       Impact factor: 12.270

3.  Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis.

Authors:  Antti I Nykänen; Rainer Krebs; Anne Saaristo; Päivi Turunen; Kari Alitalo; Seppo Ylä-Herttuala; Petri K Koskinen; Karl B Lemström
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

4.  EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.

Authors:  Injune Kim; Young Shin Ryu; Hee Jin Kwak; So Young Ahn; Jong-Lark Oh; George D Yancopoulos; Nicholas W Gale; Gou Young Koh
Journal:  FASEB J       Date:  2002-05-21       Impact factor: 5.191

5.  Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats.

Authors:  Ulrike Fiedler; Tanja Krissl; Stefanie Koidl; Cornelia Weiss; Thomas Koblizek; Urban Deutsch; Georg Martiny-Baron; Dieter Marmé; Hellmut G Augustin
Journal:  J Biol Chem       Date:  2002-11-09       Impact factor: 5.157

6.  Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway.

Authors:  I Kim; J H Kim; S O Moon; H J Kwak; N G Kim; G Y Koh
Journal:  Oncogene       Date:  2000-09-14       Impact factor: 9.867

7.  Signaling molecules in nonfamilial pulmonary hypertension.

Authors:  Lingling Du; Christopher C Sullivan; Danny Chu; Augustine J Cho; Masakuni Kido; Paul L Wolf; Jason X-J Yuan; Reena Deutsch; Stuart W Jamieson; Patricia A Thistlethwaite
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

8.  Mechanisms which mediate the antiapoptotic effects of angiopoietin-1 on endothelial cells.

Authors:  Rania Harfouche; Haroutioun M Hasséssian; Yang Guo; Valérie Faivre; Coimbatore B Srikant; George D Yancopoulos; Sabah N A Hussain
Journal:  Microvasc Res       Date:  2002-07       Impact factor: 3.514

9.  Angiopoietin-2 plays an important role in retinal angiogenesis.

Authors:  Sean F Hackett; Stanley Wiegand; George Yancopoulos; Peter A Campochiaro
Journal:  J Cell Physiol       Date:  2002-08       Impact factor: 6.384

10.  Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice.

Authors:  Z G Zhang; L Zhang; S D Croll; M Chopp
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

View more
  157 in total

1.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

2.  Angiopoietin-2 is a potential mediator of endothelial barrier dysfunction following cardiopulmonary bypass.

Authors:  Christian Clajus; Alexander Lukasz; Sascha David; Barbara Hertel; Ralf Lichtinghagen; Samir M Parikh; André Simon; Issam Ismail; Hermann Haller; Philipp Kümpers
Journal:  Cytokine       Date:  2012-07-06       Impact factor: 3.861

3.  Gab family proteins are essential for postnatal maintenance of cardiac function via neuregulin-1/ErbB signaling.

Authors:  Yoshikazu Nakaoka; Keigo Nishida; Masahiro Narimatsu; Atsunori Kamiya; Takashi Minami; Hirofumi Sawa; Katsuya Okawa; Yasushi Fujio; Tatsuya Koyama; Makiko Maeda; Manami Sone; Satoru Yamasaki; Yuji Arai; Gou Young Koh; Tatsuhiko Kodama; Hisao Hirota; Kinya Otsu; Toshio Hirano; Naoki Mochizuki
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

4.  Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs.

Authors:  Huixia Lu; Xinsheng Xu; Mei Zhang; Renhai Cao; Ebba Bråkenhielm; Changjiang Li; Huili Lin; Guihua Yao; Huiwen Sun; Lihang Qi; Mengxiong Tang; Hongyan Dai; Yanen Zhang; Runyi Su; Yanwen Bi; Yun Zhang; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-16       Impact factor: 11.205

5.  Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.

Authors:  Sirpa Loukovaara; Kaisa Lehti; Alexandra Robciuc; Timo Pessi; Juha M Holopainen; Katri Koli; Ilkka Immonen; Jorma Keski-Oja
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-12       Impact factor: 3.117

Review 6.  Controlled protein delivery in the generation of microvascular networks.

Authors:  Jillian W Andrejecsk; William G Chang; Jordan S Pober; W Mark Saltzman
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

Review 7.  Tie2 is tied at the cell-cell contacts and to extracellular matrix by angiopoietin-1.

Authors:  Shigetomo Fukuhara; Keisuke Sako; Kazuomi Noda; Kaori Nagao; Koichi Miura; Naoki Mochizuki
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

8.  Treating pulmonary arterial hypertension: current treatments and future prospects.

Authors:  Shahzad G Raja; Shahbaz M Raja
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

9.  The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.

Authors:  K Rychli; C Kaun; P J Hohensinner; G Rega; S Pfaffenberger; E Vyskocil; J M Breuss; A Furnkranz; P Uhrin; J Zaujec; A Niessner; G Maurer; K Huber; J Wojta
Journal:  J Thromb Haemost       Date:  2009-12-17       Impact factor: 5.824

Review 10.  Pathogenic mechanisms of pulmonary arterial hypertension.

Authors:  Stephen Y Chan; Joseph Loscalzo
Journal:  J Mol Cell Cardiol       Date:  2007-09-20       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.